ZNF283: A Potential Drug Target and Biomarker for Diseases (G284349)
ZNF283: A Potential Drug Target and Biomarker for Diseases
ZNF283 (HZF19) is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a key regulator of stem cell proliferation and has been linked to a number of diseases, including neurodegenerative disorders, autoimmune diseases, and stem cell cancer.
In recent years, researchers have been interested in investigating the potential drug targets of ZNF283. One of the main targets of ZNF283 is the protein p21, which is a key regulator of the cell cycle and has been linked to the development of cancer. Researchers have found that ZNF283 can interact with p21 and can inhibit its activity, which may have implications for the development of cancer.
Another potential drug target of ZNF283 is the protein PDGF-RB, which is a key regulator of stem cell proliferation and has been linked to a number of diseases, including cancer. Researchers have found that ZNF283 can interact with PDGF-RB and can inhibit its activity, which may have implications for the treatment of cancer.
In addition to its potential drug targets, ZNF283 has also been shown to be a useful biomarker for a number of diseases. For example, researchers have found that ZNF283 is expressed in the brains of individuals with Alzheimer's disease, and that it is associated with the development of this disease. Similarly, ZNF283 has been shown to be expressed in the kidneys of individuals with diabetic nephropathy, a type of diabetes-related kidney disease, and that it is associated with the development of this disease.
Overall, ZNF283 is a protein that has significant potential as a drug target and as a biomarker for a number of diseases. Further research is needed to fully understand its role and to develop effective treatments.
Protein Name: Zinc Finger Protein 283
Functions: May be involved in transcriptional regulation
The "ZNF283 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZNF283 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
ZNF284 | ZNF285 | ZNF285CP | ZNF286A | ZNF286B | ZNF287 | ZNF292 | ZNF295-AS1 | ZNF296 | ZNF3 | ZNF30 | ZNF300 | ZNF300P1 | ZNF302 | ZNF304 | ZNF311 | ZNF316 | ZNF317 | ZNF318 | ZNF319 | ZNF32 | ZNF32-AS1 | ZNF32-AS2 | ZNF32-AS3 | ZNF320 | ZNF321P | ZNF322 | ZNF322P1 | ZNF324 | ZNF324B | ZNF326 | ZNF329 | ZNF330 | ZNF331 | ZNF333 | ZNF334 | ZNF335 | ZNF337 | ZNF33A | ZNF33B | ZNF33BP1 | ZNF34 | ZNF341 | ZNF341-AS1 | ZNF343 | ZNF345 | ZNF346 | ZNF347 | ZNF35 | ZNF350 | ZNF350-AS1 | ZNF354A | ZNF354B | ZNF354C | ZNF355P | ZNF358 | ZNF362 | ZNF365 | ZNF366 | ZNF367 | ZNF37A | ZNF37BP | ZNF382 | ZNF383 | ZNF384 | ZNF385A | ZNF385B | ZNF385C | ZNF385D | ZNF385D-AS1 | ZNF385D-AS2 | ZNF391 | ZNF394 | ZNF395 | ZNF396 | ZNF397 | ZNF398 | ZNF402P | ZNF404 | ZNF407 | ZNF407-AS1 | ZNF408 | ZNF41 | ZNF410 | ZNF414 | ZNF415 | ZNF416 | ZNF417 | ZNF418 | ZNF419 | ZNF420 | ZNF423 | ZNF425 | ZNF426 | ZNF428 | ZNF429 | ZNF43 | ZNF430 | ZNF431 | ZNF432
